| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Addex Therapeutics Ltd
Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
Other Long-Term Assets
Addex Therapeutics Ltd
Other Long-Term Assets Peer Comparison
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Addex Therapeutics Ltd
SIX:ADXN
|
Other Long-Term Assets
CHf54.4k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Other Long-Term Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Long-Term Assets
$20.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Long-Term Assets
CHf44k
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-8%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Other Long-Term Assets
CHf10.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Long-Term Assets
CHf651k
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Other Long-Term Assets?
Other Long-Term Assets
54.4k
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Other Long-Term Assets amounts to 54.4k CHF.
What is Addex Therapeutics Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
0%
Over the last year, the Other Long-Term Assets growth was -9%. The average annual Other Long-Term Assets growth rates for Addex Therapeutics Ltd have been -3% over the past three years .
You don't have any saved screeners yet
